Form 8-K - Current report:
SEC Accession No. 0001558370-24-013318
Filing Date
2024-10-15
Accepted
2024-10-15 16:40:06
Documents
15
Period of Report
2024-10-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mxct-20241014x8k.htm   iXBRL 8-K 43482
2 EX-99.1 mxct-20241014xex99d1.htm EX-99.1 27942
3 GRAPHIC mxct-20241014xex99d1001.jpg GRAPHIC 5162
  Complete submission text file 0001558370-24-013318.txt   209258

Data Files

Seq Description Document Type Size
4 EX-101.SCH mxct-20241014.xsd EX-101.SCH 3267
5 EX-101.LAB mxct-20241014_lab.xml EX-101.LAB 16581
6 EX-101.PRE mxct-20241014_pre.xml EX-101.PRE 10720
17 EXTRACTED XBRL INSTANCE DOCUMENT mxct-20241014x8k_htm.xml XML 5070
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Filer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40674 | Film No.: 241372334
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)